![](/img/cover-not-exists.png)
Circulating CD19+ blood cell levels in myeloma. ECOG Myeloma Clinical Trials Laboratory Study Group [letter]
Kay, NE, Oken, MM, Bone, N, Kyle, RA, Greipp, P, Van Ness, B, Leong, TVolume:
86
Journal:
Blood
DOI:
10.1182/blood.v86.10.4000.bloodjournal86104000
Date:
November, 1995
File:
PDF, 210 KB
1995